Alkaline Corporation

Form 483 issued August 16, 2022 · Eatontown, New Jersey

Inspection
Aug 9 – Aug 16, 2022
Investigator
Frank J. Marciniak
Observations
2
Pages
4
FEI number
1000526882

In short: On August 16, 2022, FDA issued a Form 483 with 2 observations to Alkaline Corporation in Eatontown, New Jersey (FEI 1000526882) after an inspection that ran Aug 9 – Aug 16, 2022. The investigator was Frank J. Marciniak. Most observations concern design controls and production & process controls; the most-cited regulation is 21 CFR 820.30 (design controls).

At a glance

Design controls and production & process controls account for 2 of 2 observations.

Design controls1
Production & process controls1

Most cited: 21 CFR 820.30(a) (1×) · 820.75(a) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    Procedures for design control…

  2. 02

    A process whose results cannot be fully verified by subsequent inspection and test has not been…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Alkaline Corporation?

FDA listed 2 observations on this Form 483, mostly about design controls and production & process controls. The most-cited regulation is 21 CFR 820.30 (design controls). The opening words of each observation are shown on this page.

Who inspected Alkaline Corporation?

Frank J. Marciniak is named on this Form 483, for the inspection of Aug 9 – Aug 16, 2022. Each investigator has a profile showing what they cite most.

When was Alkaline Corporation inspected by FDA?

The inspection ran Aug 9 – Aug 16, 2022, and the Form 483 is dated August 16, 2022.

How do I get the full Form 483 for Alkaline Corporation?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free